Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Shenzhen Magicrna Biotechnology Co., Ltd

Clinical trials sponsored by Shenzhen Magicrna Biotechnology Co., Ltd, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New CAR-T therapy aims to calm overactive immune system in muscle weakness disease Results expected May 2027 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1 Not yet recruiting 2 Terminated 1

New cell therapy HN2301 enters human trials for autoimmune diseases

Disease control Recruiting now

This early-stage study tests a new therapy, HN2301, in 30 adults with lupus, scleroderma, or rheumatoid arthritis. The main goal is to check safety and find the right dose. Researchers will also look for early signs that the treatment helps control the disease by measuring immune…

Phase 1 • Sponsor: Shenzhen MagicRNA Biotechnology Co., Ltd • Aim: Disease control

Last updated Aug 14, 2026 00:00 UTC